Representative Legal Matters
Advised SIX-listed biopharmaceuticals company Basilea Pharmaceutica Ltd. on the completion of its repurchase offer for existing convertible bonds due 2022 and the issuance of new convertible bonds due 2027, accompanied by the provision of a stock loan facility and a delta placement of shares.
Advised SIX-listed specialty pharmaceutical company Cassiopea SpA on its capital increase of 750,000 new registered shares.
Represented SIX-listed Zur Rose Group, Europe's largest e-commerce pharmacy, on the placement of CHF 175 million Convertible Bonds due 2025.
Advised BX-Swiss-listed Varia Europe Properties AG on its capital increase of over 16 million registered shares.
Advised steel group SCHMOLZ+BICKENBACH on its recapitalization through a CHF 325 million equity capital raise against the issuance of over 1 billion new registered shares.
Represented Achiko on its listing on SIX Swiss Exchange.
Represented SIX-listed Zur Rose Group on the issuance of its 2.5% bonds due 2024.
Advised Mirion Technologies in connection with the acquisition of the dosimetry services division of Nuclear Research and consultancy Group.
Acting for Ergon Capital Partners in connection with their acquisition of the TMC Group.
Acting for Eurazeo Capital in connection with their acquisition of DORC Group.
Professional Associations and Memberships
- Dutch Bar Association
- Amsterdam~Netherlands (2016)
- University of Amsterdam (LLM Private/European Law magna cum laude) (2015)